Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis?

Rheumatology International

Volumn 33, Issue 11, 2013, Pages 2943-2948

  Radić, Mislav ^a   Kaliterna, Dušanka Martinović ^a   Bonacin, Damir ^a   Vergles, Jadranka Morović ^b   Radić, Josipa ^a   Fabijanić, Damir ^a   Kovačić, Vedran ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b University of Zagreb   (Croatia)

Author keywords

Disease activity; Disease severity; Helicobacter pylori; Systemic sclerosis

Indexed keywords

ADULT; ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LABORATORY TEST; MALE; MEDSGER SEVERITY SCALE; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SCORING SYSTEM; SKIN DISEASE; SYSTEMIC SCLEROSIS; TENDON DISEASE; VALENTINI ACTIVITY SCORE;

ADULT; AGED; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 84886717677     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2585-z     Document Type: Article

References (18)

1. Seibold JR (2005) Scleroderma. In: Harris JR Jr, Budd RC, Firestein GS, et al. (eds) Kelley's textbook's of rheumatology, 7th edn. Elsevier Saunders, Philadelphia, pp 1279-1308
2. Radic M, Martinovic Kaliterna D, Radic J (2010) Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis. Neth J Med 68:348-353
3. Amedei A, Bergman MP, Appelmelk BJ, et al. (2003) Molecular mimicry between Helicobacter pylori antigens and H+, K+-adenosine triphosphatase in human gastric autoimmunity. J Exp Med 198:1147-1156
4. Yamanishi S, Iizumi T, Watanabe E, et al. (2006) Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 74:248-256
5. Aragona P, Magazzu G, Macchia G, et al. (1999) Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren's syndrome. J Rheumatol 26:1306-1311
6. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic, Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
7. LeRoy EC, Black CM, Fleischmajer R, et al. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202-205
8. Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21(Suppl 29):S42-S46
9. Valentini G, Della Rossa A, Bombardieri S, et al. (2001) European multicentre study to define disease activity for systemic sclerosis. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60:592-598
10. Amital H, Govoni M, Maya R, et al. (2008) Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol 25(27):32
11. Ebert EC (2008) Gastric and enteric involvement in progressive systemic sclerosis. J Clin Gastroenterol 42:5-12
12. Ando T, Minami M, Ishiguro K, et al. (2006) Changes in biochemical parameters related to atherosclerosis after Helicobacter pylori eradication. Aliment Pharmacol Ther 24(Suppl 4):58-64
13. Danese S, Zoli A, Cremonini F, Gasbarrini A (2000) High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. J Rheumatol 27:1568-1569
14. Radić M, Kaliterna DM, Bonacin D, Morović Vergles J, Radić J (2010) Correlation between Helicobacter pylori infection and systemic sclerosis activity. Rheumatology (Oxford) 49:1784-1785
15. Babus V, Presecki V, Katicic M, et al. (1997) Distribution of Helicobacter pylori infection in the adult population of Croatia. Liječ Vjesn 119:139-142
16. Pounder RE, Ng D (1995) The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 9:33-39
17. Hamamdzic D, Kasman LM, LeRoy EC (2002) The role of infectious agents in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 14:694-698
18. Radić M, Kaliterna DM, Radić J (2011) Helicobacter pylori infection and systemic sclerosis - is there a link? Joint Bone Spine 78:337-340